Discontinuation report ZOSTAVAX II

Last updated on 2022-04-26 History
Report ID 159386
Drug Identification Number 02375516
Brand name ZOSTAVAX II
Common or Proper name (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
Strength(s) 19400PFU
Dosage form(s) POWDER FOR SUSPENSION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 dose vial
ATC code J07BK
ATC description VIRAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-11-03
Actual discontinuation date
Remaining supply date 2022-11-03
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-04-26 French Compare
v1 2022-04-26 English Compare

Showing 1 to 2 of 2